➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Johnson and Johnson
AstraZeneca
Harvard Business School
Dow

Last Updated: June 23, 2021

DrugPatentWatch Database Preview

Custopharm Inc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CUSTOPHARM INC, and what generic and branded alternatives to CUSTOPHARM INC drugs are available?

CUSTOPHARM INC has eight approved drugs.



Summary for Custopharm Inc
US Patents:0
Tradenames:8
Ingredients:8
NDAs:8

Drugs and US Patents for Custopharm Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Custopharm Inc PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 203619-001 Nov 13, 2017 AP RX No No   Get Started Free   Get Started Free
Custopharm Inc DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride INJECTABLE;INJECTION 210788-001 Feb 11, 2019 AP RX No No   Get Started Free   Get Started Free
Custopharm Inc ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 202605-001 Jun 13, 2016 AP RX No No   Get Started Free   Get Started Free
Custopharm Inc GANCICLOVIR SODIUM ganciclovir sodium INJECTABLE;INJECTION 212001-001 Jun 20, 2019 DISCN No No   Get Started Free   Get Started Free
Custopharm Inc VALRUBICIN valrubicin SOLUTION;INTRAVESICAL 206430-001 Apr 19, 2019 AO RX No No   Get Started Free   Get Started Free
Custopharm Inc SODIUM TETRADECYL SULFATE sodium tetradecyl sulfate INJECTABLE;INJECTION 209937-001 Dec 9, 2019 AP RX No No   Get Started Free   Get Started Free
Custopharm Inc DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate SPRAY, METERED;NASAL 211393-001 Feb 28, 2020 AB RX No No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Dow
Mallinckrodt
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.